Cladribine
disease-modifying treatment for multiple sclerosis
Nothing to addBy the Layer Nutrition editorial team · How the atlas classifies the 664 molecules
What this medicine is for
Cladribine belongs to the "disease-modifying treatment for multiple sclerosis" category. This disease-modifying treatment modulates the immune system to space out multiple sclerosis relapses.
Specifically, for Cladribine: Treats multiple sclerosis. It is most often a long-term treatment, taken at regular times over long periods; its benefit is judged over time, not by how you feel on a given day.
Under which brands it is found
In France, about 3 reimbursable presentations containing Cladribine are recorded. It comes under various trade names and in generic form.
- Leustatine
- Litak
- Mavenclad
Original brand-name products and generics deliver the same active substance; the choice between them is made with your doctor or pharmacist.
Do you need a supplement? No.
For Cladribine, we offer no supplement. No nutritional supplementation has any serious justification to set against this treatment, and we prefer to say so rather than invent a need. Our range is limited to five classes of everyday medicines for which a targeted intake makes sense; beyond these, we sell nothing for the sake of selling, and that is what gives weight to our five references.
Related molecules
To explore in the « Neurology and mind » family and its neighbours.
See the whole « Neurology and mind » family · Back to the atlas